Hollsteen
← Lumentum

Equity incl. NCI

Balance – as of period end · $M

QuartersFiscal years

$MEquity incl. NCI · Q1 FY2016: $467M · 10-Q 0001564590-15-010839 filed Nov 17, 2015Equity incl. NCI · Q2 FY2016: $471M · 10-Q 0001628280-16-010773 filed Feb 4, 2016Equity incl. NCI · Q3 FY2016: $477M · 10-Q 0001628280-16-015527 filed May 4, 2016Equity incl. NCI · Q4 FY2016: $497M · 10-K 0001628280-16-019400 filed Sep 2, 2016Equity incl. NCI · Q1 FY2017: $496M · 10-Q 0001628280-16-020392 filed Oct 27, 2016Equity incl. NCI · Q2 FY2017: $516M · 10-Q 0001633978-17-000006 filed Feb 7, 2017Equity incl. NCI · Q3 FY2017: $469M · 10-Q 0001633978-17-000037 filed May 4, 2017Equity incl. NCI · Q4 FY2017: $619M · 10-K 0001633978-17-000095 filed Aug 29, 2017Equity incl. NCI · Q1 FY2018: $641M · 10-Q 0001633978-17-000119 filed Nov 1, 2017Equity incl. NCI · Q2 FY2018: $864M · 10-Q 0001628280-18-001086 filed Feb 6, 2018Equity incl. NCI · Q3 FY2018: $877M · 10-Q 0001633978-18-000030 filed May 2, 2018Equity incl. NCI · Q4 FY2018: $926M · 10-K 0001633978-18-000108 filed Aug 28, 2018Equity incl. NCI · Q1 FY2019: $984M · 10-Q 0001628280-18-013240 filed Nov 1, 2018Equity incl. NCI · Q2 FY2019: $1.6B · 10-Q 0001633978-19-000002 filed Feb 7, 2019Equity incl. NCI · Q3 FY2019: $1.5B · 10-Q 0001633978-19-000030 filed May 7, 2019Equity incl. NCI · Q4 FY2019: $1.5B · 10-K 0001633978-19-000069 filed Aug 27, 2019Equity incl. NCI · Q1 FY2020: $1.6B · 10-Q 0001633978-19-000071 filed Oct 31, 2019Equity incl. NCI · Q2 FY2020: $1.7B · 10-Q 0001633978-20-000003 filed Feb 4, 2020Equity incl. NCI · Q3 FY2020: $1.7B · 10-Q 0001633978-20-000008 filed May 5, 2020Equity incl. NCI · Q4 FY2020: $1.7B · 10-K 0001633978-20-000011 filed Aug 25, 2020Equity incl. NCI · Q1 FY2021: $1.8B · 10-Q 0001633978-20-000018 filed Nov 2, 2020Equity incl. NCI · Q2 FY2021: $1.9B · 10-Q 0001633978-21-000004 filed Feb 2, 2021Equity incl. NCI · Q3 FY2021: $2.2B · 10-Q 0001633978-21-000009 filed May 12, 2021Equity incl. NCI · Q4 FY2021: $2.0B · 10-K 0001628280-21-017799 filed Aug 31, 2021Equity incl. NCI · Q1 FY2022: $2.0B · 10-Q 0001628280-21-021632 filed Nov 4, 2021Equity incl. NCI · Q2 FY2022: $2.0B · 10-Q 0001628280-22-001745 filed Feb 3, 2022Equity incl. NCI · Q3 FY2022: $1.9B · 10-Q 0001628280-22-012157 filed May 4, 2022Equity incl. NCI · Q4 FY2022: $1.9B · 10-K 0001628280-22-023617 filed Aug 24, 2022Equity incl. NCI · Q1 FY2023: $1.5B · 10-Q 0001628280-22-028783 filed Nov 8, 2022Equity incl. NCI · Q2 FY2023: $1.5B · 10-Q 0001628280-23-002880 filed Feb 9, 2023Equity incl. NCI · Q3 FY2023: $1.5B · 10-Q 0001628280-23-016653 filed May 9, 2023Equity incl. NCI · Q4 FY2023: $1.4B · 10-K 0001628280-23-030374 filed Aug 23, 2023Equity incl. NCI · Q1 FY2024: $1.3B · 10-Q 0001628280-23-037591 filed Nov 8, 2023Equity incl. NCI · Q2 FY2024: $1.3B · 10-Q 0001628280-24-003796 filed Feb 8, 2024Equity incl. NCI · Q3 FY2024: $1.2B · 10-Q 0001628280-24-020767 filed May 7, 2024Equity incl. NCI · Q4 FY2024: $957M · 10-K 0001628280-24-038024 filed Aug 21, 2024Equity incl. NCI · Q1 FY2025: $896M · 10-Q 0001628280-24-046443 filed Nov 8, 2024Equity incl. NCI · Q2 FY2025: $872M · 10-Q 0001628280-25-004288 filed Feb 6, 2025Equity incl. NCI · Q3 FY2025: $880M · 10-Q 0001628280-25-022788 filed May 7, 2025Equity incl. NCI · Q4 FY2025: $1.1B · 10-K 0001628280-25-040830 filed Aug 19, 2025Equity incl. NCI · Q1 FY2026: $781M · 10-Q 0001628280-25-049073 filed Nov 5, 2025Equity incl. NCI · Q2 FY2026: $847M · 10-Q 0001628280-26-005129 filed Feb 4, 2026Equity incl. NCI · Q3 FY2026: $3.0B · 10-Q 0001628280-26-030777 filed May 6, 2026Equity incl. NCI · Q4 FY2026: $4.6B · 10-K 0001628280-26-057358 filed Aug 17, 20261,5444,644467Q1 FY2016Q4 FY2026Q2 FY2023
Q2 FY2023
1,544$M
All values (44)
PeriodValue ($M)Status
Q4 FY20264,644reported
Q3 FY20262,973reported
Q2 FY2026847reported
Q1 FY2026781reported
Q4 FY20251,135reported
Q3 FY2025880reported
Q2 FY2025872reported
Q1 FY2025896reported
Q4 FY2024957reported
Q3 FY20241,177reported
Q2 FY20241,278reported
Q1 FY20241,311reported
Q4 FY20231,356reported
Q3 FY20231,538reported
Q2 FY20231,544reported
Q1 FY20231,526reported
Q4 FY20221,875reported
Q3 FY20221,912reported
Q2 FY20222,022reported
Q1 FY20221,971reported
Q4 FY20211,973reported
Q3 FY20212,165reported
Q2 FY20211,922reported
Q1 FY20211,816reported
Q4 FY20201,749reported
Q3 FY20201,734reported
Q2 FY20201,682reported
Q1 FY20201,561reported
Q4 FY20191,497reported
Q3 FY20191,504reported
Q2 FY20191,560reported
Q1 FY2019984reported
Q4 FY2018926reported
Q3 FY2018877reported
Q2 FY2018864reported
Q1 FY2018641reported
Q4 FY2017619reported
Q3 FY2017469reported
Q2 FY2017516reported
Q1 FY2017496reported
Q4 FY2016497reported
Q3 FY2016477reported
Q2 FY2016471reported
Q1 FY2016467reported

CSV with all sources · Technical ID: equity_total

More metrics for Lumentum
Sources & calculation
Value
$1.5B
Period
Q2 FY2023, ended Dec 31, 2022 · as of Dec 31, 2022 (balance as of date, not a sum)
Source
10-Q, filed Feb 9, 2023 · 0001628280-23-002880
Location
us-gaap:StockholdersEquity
Confidence
1. – directly from an XBRL fact in the filing (or calculated exactly from it)

Versions

v1$1.5BFeb 9, 202310-Q 0001628280-23-002880reported · confidence 1. · current